Shivanand Kumatagi Reflects on His Visit to Rela Hospital
Shivanand Kumatagi, Development Officer (India) at ICCBBA, shared on LinkedIn:
”Productive Visit to Rela Hospital, Chennai
I had the opportunity to visit Rela Hospital, Chennai and it was a pleasure engaging with the Transfusion Medicine team on the importance of adopting ISBT128 standardized labeling for blood and cellular therapy products.
We discussed how the increasing use of advanced technologies—including automation, barcodes, and RFID—brings tremendous benefits but also introduces new challenges related to accuracy, interoperability, and traceability.
This is exactly where standardized, globally recognized ISBT128 play a crucial role.
They help overcome these obstacles by ensuring consistency, reducing errors, and enabling seamless communication across diverse platforms and systems.
It was encouraging to see the team’s positive response and their commitment to aligning with international standards and global best practices to enhance patient safety.
Looking forward to continuing this conversation and supporting the further strengthening of transfusion services.”
Stay updated with Hemostasis Today.
-
Jan 10, 2026, 15:47Haematologica Journal Presents Review series on von Willebrand Disease
-
Jan 10, 2026, 15:15Stefan Gerner on Stroke Care and Subarachnoid Hemorrhage
-
Jan 10, 2026, 15:02Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
-
Jan 10, 2026, 14:40Last day at ASH25 from Riten Kumar
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council